EB
Emergent Biosolutions Inc
🇺🇸XNYS.EBSUnited StatesHealthcare
$6.59USDup +0.22 (+3.45%)OpenDelayed4:18 PM
Price$6.59+0.22 (+3.45%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- United States
Identity
- Exchange
- New York Stock Exchange . XNYS
- Type
- Stock
- ISIN
- US29089Q1058
- CUSIP
- 29089Q105
Company
- Employees
- 900
- Headquarters
- Gaithersburg, United States
- CEO
- Mr. Joseph C. Papa Jr., M.B.A., R.Ph.
Market
- Shares outstanding
- 51.3M
- Market cap
- $337.89M
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- $326.61M
- EPS LTM
- -$3.45calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -1.91calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $770.2M-9.56%down year on year
- Net income
- -$176.8M-226.74%down year on year
- Gross margin
- 49.4%-11.37%down year on year
- Free cash flow
- $85.9M-44.58%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.